⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29813953 | 0.88 | OPRM1 (0.31) | — | |
| Hydrochloric Acid SCHEMBL31735328 | 0.83 | SOS1 (0.31) | — | |
| SCHEMBL27034930 | 0.79 | — | — | |
| SCHEMBL23337939 | 0.76 | — | — | |
| SCHEMBL16984363 | 0.75 | — | — | |
| SCHEMBL17619450 | 0.75 | — | — | |
| SCHEMBL13893630 | 0.75 | OPRM1 (0.32) | — | |
| SCHEMBL27379131 | 0.72 | — | — | |
| SCHEMBL16627528 | 0.72 | — | — | |
| SCHEMBL25916885 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250059182-A1 | SOS1 INHIBITORS | MIRATI THERAPEUTICS, INC | 2025-02-20 | — | — | US | disclosed |
| US-11685744-B2 | CDK inhibitors and their use as pharmaceuticals | PRELUDE THERAPEUTICS INCORPORATED (US) | 2023-06-27 | — | — | US | disclosed |
| US-20220089608-A1 | CDK Inhibitors And Their Use As Pharmaceuticals | PRELUDE THERAPEUTICS, INCORPORATED | 2022-03-24 | — | — | US | disclosed |